Scalper1 News
Rising generic-drug maker Lannett Co. (LCI) beat Wall Street’s fiscal Q4 expectations but guided 2016 sales shy of estimates after the close Tuesday. Lannett’s earnings totaled 91 cents a share in the quarter ended June 30, up 42% from the year-earlier quarter, with sales up 23% to $99 million. Analysts expected earnings of 86 cents a share on revenue of $97.6 million, according to Thomson Reuters. Lannett stock was up nearly 1% in after-hours Scalper1 News
Scalper1 News